*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C9102 - Acute lymphoblastic leukemia, in relapse - as a primary diagnosis code | C9102 - Acute lymphoblastic leukemia, in relapse - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 11.54 | |
| Readmission Rate (%) | 48.75 | |
| Unplanned Readmission Rate (%) | 22.82 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 834: ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 835: ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 836: ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 014: ALLOGENEIC BONE MARROW TRANSPLANT | |
|---|---|---|---|---|
| Total Hospitalizations at DRG | 12,641 | |||
| Total Hospitalizations with ICD C9102 - Acute lymphoblastic leukemia, in relapse | 391 | |||
| DRG Share of Total Hospitalizations | 0.04 | |||
| % of Total ICD C9102 - Acute lymphoblastic leukemia, in relapse in DRG | 57.93 | |||
| Avg LOS at DRG | 16.42 | |||
| Avg LOS with ICD C9102 - Acute lymphoblastic leukemia, in relapse | 17.97 | |||
| Readmission Rate at DRG | 41.54 | |||
| Readmission Rate with ICD C9102 - Acute lymphoblastic leukemia, in relapse | 49.84 | |||
| Unplanned Readmission Rate at DRG | 17.96 | |||
| Unplanned Readmission Rate with ICD C9102 - Acute lymphoblastic leukemia, in relapse | 21.59 | |||
| Total Medicare payments at DRG | $591,889,384 | |||
| Total Medicare payments with ICD C9102 - Acute lymphoblastic leukemia, in relapse | $21,177,179 | |||
| Total Medicare payment per Day at DRG | $2,852 | |||
| Total Medicare payment per Day with ICD C9102 - Acute lymphoblastic leukemia, in relapse | $3,014 | |||
| Total Medicare payment per Hospitalization at DRG | $46,823 | |||
| Total Medicare payment per Hospitalization with ICD C9102 - Acute lymphoblastic leukemia, in relapse | $54,162 | |||
| Total Medicare Charges at DRG | $2,437,161,576 | |||
| Total Medicare Charges with ICD C9102 - Acute lymphoblastic leukemia, in relapse | $96,645,185 | |||
| Avg Charges at DRG | $192,798 | |||
| Avg Charges with ICD C9102 - Acute lymphoblastic leukemia, in relapse | $247,174 | |||
| Mortality Rate at DRG | 21.77 | |||
| Mortality Rate with ICD C9102 - Acute lymphoblastic leukemia, in relapse | 14.58 | |||
| SNF Discharge Rate at DRG | 6.6 | |||
| SNF Discharge Rate with ICD C9102 - Acute lymphoblastic leukemia, in relapse | 5.37 | |||
| Home Discharge Rate at DRG | 30.51 | |||
| Home Discharge Rate with ICD C9102 - Acute lymphoblastic leukemia, in relapse | 40.41 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 87 |
| THE UNIVERSITY OF CHICAGO MEDICAL CENTER | 5841 S. MARYLAND AVE | CHICAGO | IL | 60637 | 19 |
| HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA | 3400 SPRUCE ST | PHILADELPHIA | PA | 19104 | 17 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 834: ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 837: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 838: CHEMOTHERPY WITH ACUTE LEUKEMIA AS SDX WITH COMPLICATION OR COMORBIDITY (CC) OR HIGH DOSE CHEMOTHERAPY AGENT | DRG 835: ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 12,641 | ||||
| Total Hospitalizations with ICD C9102 - Acute lymphoblastic leukemia, in relapse | 391 | ||||
| DRG Share of Total Hospitalizations | 0.04 | ||||
| % of Total ICD C9102 - Acute lymphoblastic leukemia, in relapse in DRG | 18.11 | ||||
| Avg LOS at DRG | 16.42 | ||||
| Avg LOS with ICD C9102 - Acute lymphoblastic leukemia, in relapse | 17.97 | ||||
| Readmission Rate at DRG | 41.54 | ||||
| Readmission Rate with ICD C9102 - Acute lymphoblastic leukemia, in relapse | 49.84 | ||||
| Unplanned Readmission Rate at DRG | 17.96 | ||||
| Unplanned Readmission Rate with ICD C9102 - Acute lymphoblastic leukemia, in relapse | 21.59 | ||||
| Total Medicare payments at DRG | $591,889,384 | ||||
| Total Medicare payments with ICD C9102 - Acute lymphoblastic leukemia, in relapse | $21,177,179 | ||||
| Total Medicare payment per Day at DRG | $2,852 | ||||
| Total Medicare payment per Day with ICD C9102 - Acute lymphoblastic leukemia, in relapse | $3,014 | ||||
| Total Medicare payment per Hospitalization at DRG | $46,823 | ||||
| Total Medicare payment per Hospitalization with ICD C9102 - Acute lymphoblastic leukemia, in relapse | $54,162 | ||||
| Total Medicare Charges at DRG | $2,437,161,576 | ||||
| Total Medicare Charges with ICD C9102 - Acute lymphoblastic leukemia, in relapse | $96,645,185 | ||||
| Avg Charges at DRG | $192,798 | ||||
| Avg Charges with ICD C9102 - Acute lymphoblastic leukemia, in relapse | $247,174 | ||||
| Mortality Rate at DRG | 21.77 | ||||
| Mortality Rate with ICD C9102 - Acute lymphoblastic leukemia, in relapse | 14.58 | ||||
| SNF Discharge Rate at DRG | 6.6 | ||||
| SNF Discharge Rate with ICD C9102 - Acute lymphoblastic leukemia, in relapse | 5.37 | ||||
| Home Discharge Rate at DRG | 30.51 | ||||
| Home Discharge Rate with ICD C9102 - Acute lymphoblastic leukemia, in relapse | 40.41 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 839: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 014: ALLOGENEIC BONE MARROW TRANSPLANT | DRG 836: ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 808: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 3,028 | ||||
| Total Hospitalizations with ICD C9102 - Acute lymphoblastic leukemia, in relapse | 121 | ||||
| DRG Share of Total Hospitalizations | 0.01 | ||||
| % of Total ICD C9102 - Acute lymphoblastic leukemia, in relapse in DRG | 5.6 | ||||
| Avg LOS at DRG | 5.03 | ||||
| Avg LOS with ICD C9102 - Acute lymphoblastic leukemia, in relapse | 5.45 | ||||
| Readmission Rate at DRG | 59.48 | ||||
| Readmission Rate with ICD C9102 - Acute lymphoblastic leukemia, in relapse | 48.74 | ||||
| Unplanned Readmission Rate at DRG | 19.21 | ||||
| Unplanned Readmission Rate with ICD C9102 - Acute lymphoblastic leukemia, in relapse | 10.92 | ||||
| Total Medicare payments at DRG | $33,141,664 | ||||
| Total Medicare payments with ICD C9102 - Acute lymphoblastic leukemia, in relapse | $1,772,226 | ||||
| Total Medicare payment per Day at DRG | $2,176 | ||||
| Total Medicare payment per Day with ICD C9102 - Acute lymphoblastic leukemia, in relapse | $2,685 | ||||
| Total Medicare payment per Hospitalization at DRG | $10,945 | ||||
| Total Medicare payment per Hospitalization with ICD C9102 - Acute lymphoblastic leukemia, in relapse | $14,646 | ||||
| Total Medicare Charges at DRG | $136,817,975 | ||||
| Total Medicare Charges with ICD C9102 - Acute lymphoblastic leukemia, in relapse | $10,959,668 | ||||
| Avg Charges at DRG | $45,184 | ||||
| Avg Charges with ICD C9102 - Acute lymphoblastic leukemia, in relapse | $90,576 | ||||
| Mortality Rate at DRG | NA | ||||
| Mortality Rate with ICD C9102 - Acute lymphoblastic leukemia, in relapse | NA | ||||
| SNF Discharge Rate at DRG | 0.43 | ||||
| SNF Discharge Rate with ICD C9102 - Acute lymphoblastic leukemia, in relapse | NA | ||||
| Home Discharge Rate at DRG | 82.2 | ||||
| Home Discharge Rate with ICD C9102 - Acute lymphoblastic leukemia, in relapse | 82.64 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 315: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 829: MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 499,133 | ||||
| Total Hospitalizations with ICD C9102 - Acute lymphoblastic leukemia, in relapse | 28 | ||||
| DRG Share of Total Hospitalizations | 1.52 | ||||
| % of Total ICD C9102 - Acute lymphoblastic leukemia, in relapse in DRG | 1.3 | ||||
| Avg LOS at DRG | 4.34 | ||||
| Avg LOS with ICD C9102 - Acute lymphoblastic leukemia, in relapse | 5.54 | ||||
| Readmission Rate at DRG | 17.57 | ||||
| Readmission Rate with ICD C9102 - Acute lymphoblastic leukemia, in relapse | 56.52 | ||||
| Unplanned Readmission Rate at DRG | 12.56 | ||||
| Unplanned Readmission Rate with ICD C9102 - Acute lymphoblastic leukemia, in relapse | NA | ||||
| Total Medicare payments at DRG | $3,254,711,780 | ||||
| Total Medicare payments with ICD C9102 - Acute lymphoblastic leukemia, in relapse | $397,839 | ||||
| Total Medicare payment per Day at DRG | $1,504 | ||||
| Total Medicare payment per Day with ICD C9102 - Acute lymphoblastic leukemia, in relapse | $2,567 | ||||
| Total Medicare payment per Hospitalization at DRG | $6,521 | ||||
| Total Medicare payment per Hospitalization with ICD C9102 - Acute lymphoblastic leukemia, in relapse | $14,209 | ||||
| Total Medicare Charges at DRG | $16,863,396,143 | ||||
| Total Medicare Charges with ICD C9102 - Acute lymphoblastic leukemia, in relapse | $2,084,712 | ||||
| Avg Charges at DRG | $33,785 | ||||
| Avg Charges with ICD C9102 - Acute lymphoblastic leukemia, in relapse | $74,454 | ||||
| Mortality Rate at DRG | 1.33 | ||||
| Mortality Rate with ICD C9102 - Acute lymphoblastic leukemia, in relapse | NA | ||||
| SNF Discharge Rate at DRG | 19.89 | ||||
| SNF Discharge Rate with ICD C9102 - Acute lymphoblastic leukemia, in relapse | NA | ||||
| Home Discharge Rate at DRG | 49.27 | ||||
| Home Discharge Rate with ICD C9102 - Acute lymphoblastic leukemia, in relapse | 50.0 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 864: FEVER | DRG 919: COMPLICATIONS OF TREATMENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 522,791 | ||||
| Total Hospitalizations with ICD C9102 - Acute lymphoblastic leukemia, in relapse | 19 | ||||
| DRG Share of Total Hospitalizations | 1.59 | ||||
| % of Total ICD C9102 - Acute lymphoblastic leukemia, in relapse in DRG | 0.88 | ||||
| Avg LOS at DRG | 3.14 | ||||
| Avg LOS with ICD C9102 - Acute lymphoblastic leukemia, in relapse | 3.74 | ||||
| Readmission Rate at DRG | 17.1 | ||||
| Readmission Rate with ICD C9102 - Acute lymphoblastic leukemia, in relapse | NA | ||||
| Unplanned Readmission Rate at DRG | 12.62 | ||||
| Unplanned Readmission Rate with ICD C9102 - Acute lymphoblastic leukemia, in relapse | NA | ||||
| Total Medicare payments at DRG | $2,290,151,156 | ||||
| Total Medicare payments with ICD C9102 - Acute lymphoblastic leukemia, in relapse | $113,306 | ||||
| Total Medicare payment per Day at DRG | $1,394 | ||||
| Total Medicare payment per Day with ICD C9102 - Acute lymphoblastic leukemia, in relapse | $1,596 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,381 | ||||
| Total Medicare payment per Hospitalization with ICD C9102 - Acute lymphoblastic leukemia, in relapse | $5,963 | ||||
| Total Medicare Charges at DRG | $13,619,287,561 | ||||
| Total Medicare Charges with ICD C9102 - Acute lymphoblastic leukemia, in relapse | $781,180 | ||||
| Avg Charges at DRG | $26,051 | ||||
| Avg Charges with ICD C9102 - Acute lymphoblastic leukemia, in relapse | $41,115 | ||||
| Mortality Rate at DRG | 0.18 | ||||
| Mortality Rate with ICD C9102 - Acute lymphoblastic leukemia, in relapse | NA | ||||
| SNF Discharge Rate at DRG | 8.57 | ||||
| SNF Discharge Rate with ICD C9102 - Acute lymphoblastic leukemia, in relapse | NA | ||||
| Home Discharge Rate at DRG | 72.49 | ||||
| Home Discharge Rate with ICD C9102 - Acute lymphoblastic leukemia, in relapse | 84.21 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 173 |
| MASSACHUSETTS GENERAL HOSPITAL | 55 FRUIT ST | BOSTON | MA | 02114 | 66 |
| CITY OF HOPE DUARTE | 1500 E DUARTE RD | DUARTE | CA | 91010 | 47 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. PHILIP CRAWFORD AMREIN | 55 FRUIT ST YAW 7 | BOSTON | MA | 02114 | 12 |
| Dr. YESID ALVARADO VALERO | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 11 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. PHILIP CRAWFORD AMREIN | 55 FRUIT ST YAW 7 | BOSTON | MA | 02114 | 14 |
| Dr. YESID ALVARADO VALERO | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 12 |
| Dr. IBRAHIM TAHA ALDOSS | 1500 E. DUARTE RD. | DUARTE | CA | 91010 | 12 |